BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 29690860)

  • 21. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC.
    Kim KM; Park SH; Bae JS; Noh SJ; Tao GZ; Kim JR; Kwon KS; Park HS; Park BH; Lee H; Chung MJ; Moon WS; Sylvester KG; Jang KY
    Sci Rep; 2017 Jun; 7(1):3274. PubMed ID: 28607447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.
    Liu H; Wu Q; Liu Y; Liu W; Zhang W; Pan D; Xu J
    Jpn J Clin Oncol; 2015 Sep; 45(9):844-53. PubMed ID: 26056329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher PKD3 expression in hepatocellular carcinoma (HCC) tissues predicts poorer prognosis for HCC patients.
    Yang H; Xu M; Chi X; Yan Q; Wang Y; Xu W; Zhuang K; Li A; Liu S
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):554-563. PubMed ID: 28363424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
    Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery.
    Dai CX; Gao Q; Qiu SJ; Ju MJ; Cai MY; Xu YF; Zhou J; Zhang BH; Fan J
    BMC Cancer; 2009 Dec; 9():418. PubMed ID: 19948069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
    Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
    Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients.
    Peng L; Yuan XQ; Zhang CY; Ye F; Zhou HF; Li WL; Liu ZY; Zhang YQ; Pan X; Li GC
    Oncotarget; 2017 May; 8(21):34387-34397. PubMed ID: 28415739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
    Wang Y; Huang Q; Deng T; Li BH; Ren XQ
    Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
    Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M
    Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship and clinical significance of TGF-beta1 expression with Treg cell infiltration in hepatocellular carcinoma.
    Lin GH; Wang J; Li SH; Wang J; Xu L; Li SP
    Chin J Cancer; 2010 Apr; 29(4):403-7. PubMed ID: 20346216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
    Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
    J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis.
    Zhou H; Wang SC; Ma JM; Yu LQ; Jing JS
    Med Sci Monit; 2018 Aug; 24():6021-6028. PubMed ID: 30157168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
    PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
    Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
    Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
    Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
    Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.